TRIM29 overexpression at mRNA and protein level is apparent in TNBC compared to all other breast cancer subtypes in TCGA and CPTAC datasets, and its higher expression correlates to worse recurrence free survival in TNBC patients indicating an important role in TNBC. Here, TRIM29 is linked to breast carcinoma.